Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axogen Inc (NQ: AXGN )

8.840 +0.200 (+2.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axogen Inc

< Previous 1 2 Next >
Axogen to Participate at Jefferies Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at JMP Securities Life Sciences Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Reports 2023 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023
From Axogen, Inc.
Via GlobeNewswire
Axogen Earnings Perspective: Return On Capital Employed
 
Via Benzinga
A Preview Of Axogen's Earnings
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023
From Axogen, Inc.
Via GlobeNewswire
Read JMP Securities' Take On Axogen's Interim Update
 
Via Benzinga
Axogen Aces Phase 3 Study For Avance Nerve Graft
 
Via Benzinga
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
From Axogen, Inc.
Via GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits
Study concluded allograft and autograft repairs delivered significantly better rates of meaningful sensory recovery in short gaps as compared to conduit repairs in a systematic meta-analysis including... 
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
From Axogen, Inc.
Via GlobeNewswire
Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc Reports 2022 Third Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.
Dr. Tyndall is currently the Executive Vice President for Health Affairs and Dean of Morehouse School of Medicine. 
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022
From Axogen, Inc.
Via GlobeNewswire
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in... 
Via Benzinga
Axogen: Q2 Earnings Insights
Axogen (NASDAQ:AXGN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axogen beat estimated earnings by... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022
Upgrades 
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Drops 650 Points; Silicon Motion Shares Spike Higher
U.S. stocks remained lower toward the end of trading, with the Nasdaq Composite dropping more than 650 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
83 Biggest Movers From Yesterday
Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results. 
Via Benzinga
Mid-Day Market Update: U.S. Stocks Extend Losses; Dow Dips Over 1,100 Points
U.S. stocks extended losses midway through trading, with the Dow Jones dipping more than 1,100 points on Thursday. 
Via Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.